Zacks Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $67.1M | Sell |
530,870
-4,922
| -0.9% | -$649K | 0.48% | 62 |
|
|
2026
Q1 | $74.7M | Sell |
535,792
-12,265
| -2% | -$1.72M | 0.6% | 46 |
|
|
2025
Q4 | $67.3M | Buy |
548,057
+94,472
| +21% | +$11.5M | 0.53% | 50 |
|
|
2025
Q3 | $50.3M | Buy |
453,585
+5,616
| +1% | +$638K | 0.4% | 70 |
|
|
2025
Q2 | $49.7M | Buy |
447,969
+3,196
| +0.7% | +$340K | 0.42% | 68 |
|
|
2025
Q1 | $49.8M | Buy |
444,773
+109,800
| +33% | +$11.3M | 0.47% | 63 |
|
|
2024
Q4 | $30.9M | Sell |
334,973
-34,385
| -9% | -$3.1M | 0.29% | 92 |
|
|
2024
Q3 | $31M | Buy |
369,358
+33,099
| +10% | +$2.53M | 0.27% | 98 |
|
|
2024
Q2 | $23.1M | Buy |
336,259
+7,438
| +2% | +$496K | 0.26% | 97 |
|
|
2024
Q1 | $24.1M | Sell |
328,821
-388,768
| -54% | -$29.9M | 0.26% | 97 |
|
|
2023
Q4 | $58.1M | Sell |
717,589
-34,211
| -5% | -$2.66M | 0.72% | 39 |
|
|
2023
Q3 | $56.3M | Buy |
751,800
+2,293
| +0.3% | +$176K | 0.73% | 38 |
|
|
2023
Q2 | $57.8M | Buy |
749,507
+5,933
| +0.8% | +$473K | 0.73% | 40 |
|
|
2023
Q1 | $61.7M | Buy |
743,574
+21,503
| +3% | +$1.78M | 0.83% | 35 |
|
|
2022
Q4 | $62M | Buy |
722,071
+135,927
| +23% | +$10.8M | 0.87% | 32 |
|
|
2022
Q3 | $36.2M | Buy |
586,144
+17,202
| +3% | +$1.08M | 0.58% | 53 |
|
|
2022
Q2 | $35.2M | Buy |
568,942
+31,470
| +6% | +$1.95M | 0.54% | 61 |
|
|
2022
Q1 | $32M | Buy |
537,472
+30,678
| +6% | +$1.96M | 0.44% | 68 |
|
|
2021
Q4 | $36.8M | Buy |
506,794
+7,703
| +2% | +$531K | 0.52% | 55 |
|
|
2021
Q3 | $34.9M | Buy |
499,091
+13,168
| +3% | +$925K | 0.55% | 56 |
|
|
2021
Q2 | $33.5M | Buy |
485,923
+23,480
| +5% | +$1.57M | 0.54% | 57 |
|
|
2021
Q1 | $29.9M | Sell |
462,443
-18,938
| -4% | -$1.22M | 0.53% | 63 |
|
|
2020
Q4 | $28M | Sell |
481,381
-106,991
| -18% | -$6.46M | 0.52% | 65 |
|
|
2020
Q3 | $37.2M | Buy |
588,372
+75,632
| +15% | +$5.24M | 0.75% | 43 |
|
|
2020
Q2 | $39.5M | Sell |
512,740
-25,999
| -5% | -$1.99M | 0.87% | 41 |
|
|
2020
Q1 | $40.3M | Buy |
538,739
+28,364
| +6% | +$1.96M | 0.99% | 35 |
|
|
2019
Q4 | $33.2M | Sell |
510,375
-23,915
| -4% | -$1.56M | 0.62% | 52 |
|
|
2019
Q3 | $33.9M | Buy |
534,290
+12,082
| +2% | +$790K | 0.68% | 48 |
|
|
2019
Q2 | $35.3M | Buy |
522,208
+6,367
| +1% | +$419K | 0.72% | 45 |
|
|
2019
Q1 | $33.5M | Buy |
515,841
+20,974
| +4% | +$1.39M | 0.72% | 46 |
|
|
2018
Q4 | $31M | Sell |
494,867
-33,231
| -6% | -$2.32M | 0.75% | 45 |
|
|
2018
Q3 | $40.8M | Sell |
528,098
-26,158
| -5% | -$1.98M | 0.85% | 38 |
|
|
2018
Q2 | $39.3M | Buy |
554,256
+4,211
| +0.8% | +$297K | 0.85% | 36 |
|
|
2018
Q1 | $41.5M | Buy |
550,045
+5,663
| +1% | +$450K | 0.92% | 30 |
|
|
2017
Q4 | $39M | Sell |
544,382
-56,503
| -9% | -$4.29M | 0.85% | 37 |
|
|
2017
Q3 | $48.7M | Buy |
600,885
+574,658
| +2,191% | +$43.9M | 1.14% | 25 |
|
|
2017
Q2 | $1.86M | Buy |
26,227
+22,911
| +691% | +$1.52M | 0.05% | 249 |
|
|
2017
Q1 | $225K | Sell |
3,316
-67,688
| -95% | -$4.76M | 0.01% | 549 |
|
|
2016
Q4 | $5.08M | Sell |
71,004
-26,949
| -28% | -$2M | 0.15% | 132 |
|
|
2016
Q3 | $7.75M | Sell |
97,953
-23,488
| -19% | -$1.91M | 0.22% | 104 |
|
|
2016
Q2 | $10.1M | Sell |
121,441
-5,321
| -4% | -$472K | 0.31% | 85 |
|
|
2016
Q1 | $11.6M | Buy |
126,762
+6,502
| +5% | +$586K | 0.37% | 81 |
|
|
2015
Q4 | $12.2M | Sell |
120,260
-15,020
| -11% | -$1.56M | 0.4% | 77 |
|
|
2015
Q3 | $13.3M | Sell |
135,280
-3,584
| -3% | -$398K | 0.46% | 71 |
|
|
2015
Q2 | $16.3M | Buy |
138,864
+1,981
| +1% | +$216K | 0.52% | 68 |
|
|
2015
Q1 | $13.4M | Sell |
136,883
-1,042
| -0.8% | -$106K | 0.43% | 84 |
|
|
2014
Q4 | $13M | Sell |
137,925
-68,779
| -33% | -$7.11M | 0.42% | 81 |
|
|
2014
Q3 | $22M | Sell |
206,704
-4,117
| -2% | -$403K | 0.77% | 38 |
|
|
2014
Q2 | $17.5M | Buy |
210,821
+63,870
| +43% | +$4.97M | 0.62% | 47 |
|
|
2014
Q1 | $10.4M | Buy |
146,951
+34,680
| +31% | +$2.72M | 0.39% | 92 |
|
|
2013
Q4 | $8.43M | Sell |
112,271
-10,589
| -9% | -$737K | 0.33% | 111 |
|
|
2013
Q3 | $7.72M | Sell |
122,860
-9,398
| -7% | -$562K | 0.33% | 114 |
|
|
2013
Q2 | $6.78M | Buy |
+132,258
| New | +$6.89M | 0.31% | 122 |
|
Other funds holding GILD
Zacks Investment Management's GILD Position: Q2 2026 in Review
Zacks Investment Management reduced its Gilead Sciences (GILD) stake by 0.92% in Q2 2026, selling an estimated $649K and leaving 530,870 shares worth $67.1M. The position accounts for 0.48% of the portfolio, ranked #62.
Zacks Investment Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $74.7M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Zacks Investment Management held 530,870 shares of Gilead Sciences worth $67.1M as of Q2 2026.
- Zacks Investment Management sold 4,922 Gilead Sciences shares in Q2 2026, an estimated $649K.
- Gilead Sciences made up 0.48% of Zacks Investment Management's portfolio in Q2 2026, its #62 holding.
- Zacks Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Zacks Investment Management's Gilead Sciences position peaked at $74.7M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.